Aprea Therapeutics | DEFA14A: Others
Apr 25 07:20 ET
Aprea Therapeutics | DEF 14A: Definitive information statements
Apr 25 07:05 ET
Aprea Therapeutics | 8-K: Current report
Apr 10 16:19 ET
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Apr 3 16:11 ET
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Mar 26 08:19 ET
Aprea Therapeutics | 8-K: Current report
Mar 12 16:35 ET
Aprea Therapeutics | 8-K: Current report
Feb 6 17:03 ET
Aprea Therapeutics | 8-K: Current report
Feb 2 16:32 ET
Aprea Therapeutics | 8-K: Current report
Jan 26 07:18 ET
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Jan 26 06:09 ET
Aprea Therapeutics | 8-K: Current report
Jan 4 00:00 ET
Aprea Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Nov 9, 2023 16:20 ET
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
Nov 9, 2023 16:15 ET
Aprea Therapeutics | 8-K: Current report
Oct 16, 2023 17:29 ET
Aprea Therapeutics | 8-K: Current report
Oct 13, 2023 07:31 ET
Aprea Therapeutics | 8-K: Current report
Sep 11, 2023 08:30 ET
Aprea Therapeutics | 8-K: Current report
Aug 24, 2023 08:00 ET
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Second Quarter 2023 Financial Results and Provides Update on Business Operations
Aug 10, 2023 07:36 ET
Aprea Therapeutics | DEF 14A: Definitive information statements
Jul 11, 2023 07:30 ET
Aprea Therapeutics | 8-K: Current report
Jul 5, 2023 16:01 ET
No Data
No Data